DNAH10 and lung adenocarcinoma: Moreover, no significant difference in OS was found in patients with The Cancer Genome Atlas Lung Adenocarcinoma (TCGA-LUAD) or The Cancer Genome Atlas Lung Squamous Cell Carcinoma (TCGA-LUSC) (P = 0.2668 vs. P = 0.7193, respectively, Figure 3C–3D) with and without DNAH10 mutation.